The effects of PCB126 on intra-hepatic mechanisms associated with non alcoholic fatty liver disease

• Published in: Journal of diabetes and metabolic disorders Vol. 14; no. 1; p. 88
• Main Authors: Boucher, Marie-Pier, Lefebvre, Caroline, Chapados, Natalie Ann
• Format: Journal Article
• Language: English
• Published: London BioMed Central 10.12.2015; BioMed Central Ltd
• Subjects: Diabetes; Endocrine disruptors; Endocrinology; Fatty liver; Fireproofing agents; Medicine & Public Health; Metabolic Diseases; Persistent organic pollutants; Pesticides; Polychlorinated biphenyls; Protein binding; Research Article; Triglycerides; Rats; Environmental contaminants; Liver; Steatosis
• ISSN: 2251-6581; 2251-6581
• DOI: 10.1186/s40200-015-0218-2

Background Non alcoholic fatty liver disease (NAFLD) results from alteration in lipid synthesis and elimination mechanisms such as very-low density lipoprotein (VLDL) production and de novo lipogenesis. Persistent organic pollutants (POPs) are chemicals that were mostly used historically as pesticides, solvents, flame retardant, and other applications. Among POPs, polychlorinated biphenyls (PCB) have been recognized to be of environmental and potential toxicologic concerns. Specifically, PCB126 could act as endocrine disruptors and has recently been associated with hepatic fat accumulation. The purpose of the study was to investigate the effects of PCB126 on the molecular development of NAFLD using hepatocyte and rat models. Methods Hepatocytes were exposed to PCB 126 for 72 h and lipid accumulation in cells was quantified by Oil-Red-O. Rats were injected with a single dose of PCB126 or vehicle. Seven days later, liver triglycerides (TAG) content was measured along with protein quantification of hepatic microsomal triglyceride transfer protein (MTP), sterol regulatory element-binding protein 1c (SREBP1c) and diacylglycerol O-acyltransferase 2 (DGAT-2). Results Exposure to PCB126 resulted in significant increases of lipid accumulation in hepatocytes (38 %, P <0.05) and hepatic TAG concentrations (64 %, P <0.001) in rats compared to respective control groups. Rats with fatty livers depicted lower MTP (40 %, P <0.02), higher SREBP1c (27 %, P  < 0.05) and DGAT-2 (120 %, P  < 0.02) protein content levels compared to Placebo group in rats. Conclusions It seems that exposure to PCB126 has an important emerging role in the pathophysiology of NAFLD by 1) altering elimination mechanisms such as VLDL synthesis and secretion, through MTP; and 2) increasing hepatic TAG synthesis mechanisms through DGAT 2 and SREBP1c.